Jennifer Lachey

Insider Reports History

Location
Lexington, MA
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer Lachey:

Form 4 holding Chief Scientific Officer

Keros Therapeutics, Inc.

Security class
Common Stock
Shares / value
95,100
Estimated value
$4,307,079
Report date
15 Jul 2022
Price
$45.29
Ownership
Direct
Form 4 holding Chief Scientific Officer

Keros Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
8,755
Estimated value
Report date
15 Jul 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jennifer Lachey

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .